Cited by 231Lymphoma Diagnosis and TreatmentViral-associated cancers and disordersHematological disorders and diagnostics

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions

Open access
Turner, Jennifer J., Morton, Lindsay M., Linet, Martha S., Clarke, Christina A., Kadin, Marshall E., Vajdic, Claire M., Monnereau, Alain, Maynadié, Marc +5 more·2010·Blood

Abstract

After publication of the updated World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues in 2008, the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) now presents an update of the hierarchical classification of lymphoid neoplasms for epidemiologic research based on the 2001 WHO classification, which we published in 2007. The updated hierarchical classification incorporates all of the major and provisional entities in the 2008 WHO classification, including newly defined entities based on age, site, certain infections, and molecular characteristics, as well as borderline categories, early and “in situ” lesions, disorders with limited capacity for clinical progression, lesions without current International Classification of Diseases for Oncology, 3rd Edition codes, and immunodeficiency-associated lymphoproliferative disorders. WHO subtypes are defined in hierarchical groupings, with newly defined groups for small B-cell lymphomas with plasmacytic differentiation and for primary cutaneous T-cell lymphomas. We suggest approaches for applying the hierarchical classification in various epidemiologic settings, including strategies for dealing with multiple coexisting lymphoma subtypes in one patient, and cases with incomplete pathologic information. The pathology materials useful for state-of-the-art epidemiology studies are also discussed. We encourage epidemiologists to adopt the updated InterLymph hierarchical classification, which incorporates the most recent WHO entities while demonstrating their relationship to older classifications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2010-06-289561

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 45 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Percy C, Fritz A, Ries L. Conversion of neo- plasms by topography and morphology from the International Classification of Diseases for Oncol- ogy, second edition, to International Classification of Diseases for Oncology, 3d ed. Cancer Statis- tics Branch, DCCPS, SEER Program, National Cancer Institute; 2001.
  2. Kim H, Hendrickson R, Dorfman RF. Composite lymphoma. Cancer. 1977;40(3):959-976.

Cited by

Sorted by citations

Authors
Turner, J. J., Morton, L. M., Linet, M. S., Clarke, C. A., Kadin, M. E., Vajdic, C. M., Monnereau, A., Maynadié, M., Chiu, B. C.-H., Marcos-Gragera, R., Costantini, A. S., Cerhan, J. R., & Weisenburger, D. D.
Affiliations
  • Douglass Hanly Moir Pathology (AU)
  • National Institutes of Health (US)
  • Cancer Prevention Institute of California (US)
  • Boston University (US)
  • UNSW Sydney (AU)
  • Inserm (FR)
  • Université de Bourgogne (FR)
  • University of Chicago (US)
  • Epidemiology Unit, Cancer Registry of Girona, Oncology Planning, Department of Health, Institute of Biomedical Investigation, Girona, Spain;
  • Cancer Research and Prevention Institute Epidemiology, Florence, Italy;
  • Mayo Clinic (US)
  • University of Nebraska Medical Center (US)
Venue
Blood
Published
2010-11-18
Volume
116
Issue
20
Pages
e90-e98
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2070728536
Cited by
231
References
45
Citations by year
2026: 3 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 19 · 2019: 11 · 2018: 15 · 2017: 7 · 2016: 18 · 2015: 25 · 2014: 39 · 2013: 25 · 2012: 16
FWCI
10.65
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health and Human Services
  • National Institutes of Health (CA97274)
  • National Cancer Institute (CA97274, R01 CA97274, R01CA092153, P50CA097274)
  • National Center for Research Resources (P20RR018757)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Emergency Medicine › Hematological disorders and diagnostics
Keywords
lymphoid malignancies, hierarchical classification, lymphoma epidemiology, lymphoma subtypes, primary cutaneous T-cell lymphoma
MeSH terms
Humans, Lymphoma, Societies, Medical, World Health Organization, Epidemiologic Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review